Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for …
A Kerschbaumer, A Sepriano, JS Smolen… - Annals of the …, 2020 - ard.bmj.com
Objectives To inform the 2019 update of the European League against Rheumatism
(EULAR) recommendations for the management of rheumatoid arthritis (RA). Methods A …
(EULAR) recommendations for the management of rheumatoid arthritis (RA). Methods A …
[HTML][HTML] An expert consensus framework for asthma remission as a treatment goal
A Menzies-Gow, M Bafadhel, WW Busse… - Journal of Allergy and …, 2020 - Elsevier
With novel therapies in development, there is an opportunity to consider asthma remission
as a treatment goal. In this Rostrum, we present a generalized framework for clinical and …
as a treatment goal. In this Rostrum, we present a generalized framework for clinical and …
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
L Gossec, X Baraliakos, A Kerschbaumer… - Annals of the …, 2020 - ard.bmj.com
Objective To update the European League Against Rheumatism (EULAR) recommendations
for the pharmacological treatment of psoriatic arthritis (PsA). Methods According to the …
for the pharmacological treatment of psoriatic arthritis (PsA). Methods According to the …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
JS Smolen, RBM Landewé, JWJ Bijlsma… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …
rheumatoid arthritis (RA) management recommendations to account for the most recent …
Treg cells in health and autoimmune diseases: New insights from single cell analysis
C Scheinecker, L Göschl, M Bonelli - Journal of autoimmunity, 2020 - Elsevier
Autoimmune diseases, such as Systemic Lupus Erythematosus (SLE) or Rheumatoid
Arthritis (RA) are characterized by the breakdown of immunological tolerance. Defects of …
Arthritis (RA) are characterized by the breakdown of immunological tolerance. Defects of …
Understanding the role of interleukin-6 (IL-6) in the joint and beyond: a comprehensive review of IL-6 inhibition for the management of rheumatoid arthritis
EG Favalli - Rheumatology and therapy, 2020 - Springer
Rheumatoid arthritis (RA) is a chronic, debilitating autoimmune disorder involving
inflammation and progressive destruction of the joints, affecting up to 1% of the population …
inflammation and progressive destruction of the joints, affecting up to 1% of the population …
Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention
HG Raterman, IE Bultink, WF Lems - Expert opinion on …, 2020 - Taylor & Francis
Introduction Rheumatoid arthritis (RA) is a chronic disabling disease characterized by a
symmetrical articular involvement due to ongoing joint inflammation, if left insufficiently …
symmetrical articular involvement due to ongoing joint inflammation, if left insufficiently …
2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis
B Bech, J Primdahl, A van Tubergen… - Annals of the …, 2020 - ard.bmj.com
To update the European League Against Rheumatism (EULAR) recommendations for the
role of the nurse in the management of chronic inflammatory arthritis (CIA) using the most up …
role of the nurse in the management of chronic inflammatory arthritis (CIA) using the most up …
Efficacy and safety of PF‐06651600 (Ritlecitinib), a novel Jak3/TEC inhibitor, in patients with Moderate‐To‐Severe rheumatoid arthritis and an inadequate response to …
MF Robinson, N Damjanov… - Arthritis & …, 2020 - Wiley Online Library
Objective To evaluate the efficacy and safety of PF‐06651600 (ritlecitinib), an irreversible
inhibitor of JAK3 and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) …
inhibitor of JAK3 and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) …
Epidemiological characteristics of rheumatoid arthritis in Japan: prevalence estimates using a nationwide population-based questionnaire survey
M Kojima, T Nakayama, K Tsutani… - Modern …, 2020 - academic.oup.com
Objectives: To elucidate the epidemiological characteristics of patients with rheumatoid
arthritis (RA) in Japan using data from the Comprehensive Survey of Living Conditions, a …
arthritis (RA) in Japan using data from the Comprehensive Survey of Living Conditions, a …